Page 6,747«..1020..6,7466,7476,7486,749..6,7606,770..»

FDA Approves Lyrica For The Management Of Neuropathic Pain Associated With Spinal Cord Injury Based On Priority Review

Posted: Published on June 21st, 2012

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (PFE) announced today that the U.S. Food and Drug Administration (FDA) approved the use of Lyrica (pregabalin) capsules CV for the management of neuropathic pain associated with spinal cord injury. Lyrica received a priority review designation for this new indication from the FDA. More than 100,000 patients approximately 40 percent of the 270,000 patients with spinal cord injury in the United States - suffer from this chronic, complex pain condition. Neuropathic pain associated with spinal cord injury can be severely debilitating and may significantly hinder rehabilitation and the ability to regain function. This milestone represents an important opportunity for physicians to more effectively manage the debilitating neuropathic pain that often accompanies spinal cord injury, said clinical study investigator Diana Cardenas, MD, MHA, professor and chair, department of rehabilitation medicine, University of Miami Miller School of Medicine and chief of service for rehabilitation medicine and medical director of Jackson Rehabilitation Hospital, Miami, Florida. Given the clinical challenges of investigating neuropathic pain in this patient population, any advancements in treatment are welcome by physicians and patients alike. An estimated 12,000 new spinal cord injury patients are diagnosed in the U.S. each year. There are a wide variety … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on FDA Approves Lyrica For The Management Of Neuropathic Pain Associated With Spinal Cord Injury Based On Priority Review

Treating Orthostatic Hypotension Improves Function In Parkinson's Disease Patients, According To Braintree …

Posted: Published on June 21st, 2012

BOSTON, June 21, 2012 /PRNewswire/ --A new study analyzing patient data from Braintree Rehabilitation Hospital in Braintree, Massachusetts, found that blood pressure fluctuations can worsen symptoms of Parkinson's disease. Conversely, after treating Parkinson's disease patients who experienced blood pressure drops when changing from a sitting to standing position, improvements were noted in cognitive function, balance and walking, according to the researchers at Braintree Rehabilitation Hospital. Information from the study will be presented today at the Movement Disorder Society's 16th International Congress of Parkinson's Disease and Movement Disorders in Dublin, Ireland. The corresponding abstract, "Treating Orthostatic Hypotension in Patients with Parkinson's and Atypical Parkinsonism Improves Function," will be published as an electronic supplement to The Movement Disorders Journal online edition at http://www.movementdisorders.org. "This new research sheds light for better Parkinson's disease treatment, as blood pressure can be affected by the disease and problems often worsen over time," said Dr. Anna DePold Hohler, Medical Director of the Movement Disorders Program at Braintree Rehabilitation Hospital and Associate Professor of Neurology at Boston University Medical Center, who participated in the study. "The good news for Parkinson's disease patients is that implementing simple interventions, monitored by a physician, can significantly improve functionality." In the United … Continue reading

Posted in Parkinson's Treatment | Comments Off on Treating Orthostatic Hypotension Improves Function In Parkinson's Disease Patients, According To Braintree …

Brain Stimulation for Parkinson’s Offers Improvements in Symptoms Over Three Years

Posted: Published on June 21st, 2012

WASHINGTON--(BUSINESS WIRE)-- Patients with Parkinsons disease who undergo deep brain stimulation (DBS)a treatment in which a pacemaker-like device sends pulses to electrodes implanted in the braincan expect stable improvement in muscle symptoms for at least three years, according to a Department of Veterans Affairs study appearing in the most recent issue of the journal Neurology. VA was proud to partner with the National Institutes of Health in this research, said Secretary of Veterans Affairs Eric K. Shinseki. Our research on Parkinsons helps ensure we continue to provide the best care possible for Veterans with this debilitating disease. VA cares for some 40,000 Veterans with the condition. In DBS, surgeons implant electrodes in the brain and run thin wires under the skin to a pacemaker-like device placed at one of two locations in the brain. Electrical pulses from the battery-operated device jam the brain signals that cause muscle-related symptoms. Thousands of Americans have seen successful results from the procedure since it was first introduced in the late 1990s. But questions have remained about which stimulation site in the brain yields better outcomes, and over how many years the gains persist. Initial results from the study appeared in 2009 in the Journal … Continue reading

Posted in Parkinson's Treatment | Comments Off on Brain Stimulation for Parkinson’s Offers Improvements in Symptoms Over Three Years

Functional links between autism and genes explained

Posted: Published on June 21st, 2012

ScienceDaily (June 21, 2012) A pioneering report of genome-wide gene expression in autism spectrum disorders (ASDs) finds genetic changes that help explain why one person has an ASD and another does not. The study, published by Cell Press on June 21 in The American Journal of Human Genetics, pinpoints ASD risk factors by comparing changes in gene expression with DNA mutation data in the same individuals. This innovative approach is likely to pave the way for future personalized medicine, not just for ASD but also for any disease with a genetic component. ASDs are a heterogeneous group of developmental conditions characterized by social deficits, difficulty communicating, and repetitive behaviors. ASDs are thought to be highly heritable, meaning that they run in families. However, the genetics of autism are complex. Researchers have found rare changes in the number of copies of defined genetic regions that associate with ASD. Although there are some hot-spot regions containing these alterations, very few genetic changes are exactly alike. Similarly, no two autistic people share the exact same symptoms. To discover how these genetic changes might affect gene transcription and, thus, the presentation of the disorder, Rui Luo, a graduate student in the Geschwind lab at … Continue reading

Comments Off on Functional links between autism and genes explained

Study explains functional links between autism and genes

Posted: Published on June 21st, 2012

Public release date: 21-Jun-2012 [ | E-mail | Share ] Contact: Mary Beth O'Leary moleary@cell.com 617-397-2802 Cell Press A pioneering report of genome-wide gene expression in autism spectrum disorders (ASDs) finds genetic changes that help explain why one person has an ASD and another does not. The study, published by Cell Press on June 21 in The American Journal of Human Genetics, pinpoints ASD risk factors by comparing changes in gene expression with DNA mutation data in the same individuals. This innovative approach is likely to pave the way for future personalized medicine, not just for ASD but also for any disease with a genetic component. ASDs are a heterogeneous group of developmental conditions characterized by social deficits, difficulty communicating, and repetitive behaviors. ASDs are thought to be highly heritable, meaning that they run in families. However, the genetics of autism are complex. Researchers have found rare changes in the number of copies of defined genetic regions that associate with ASD. Although there are some hot-spot regions containing these alterations, very few genetic changes are exactly alike. Similarly, no two autistic people share the exact same symptoms. To discover how these genetic changes might affect gene transcription and, thus, the … Continue reading

Comments Off on Study explains functional links between autism and genes

'Master molecule' may improve stem cell treatment of heart attacks

Posted: Published on June 21st, 2012

Public release date: 20-Jun-2012 [ | E-mail | Share ] Contact: Phil Sneiderman prs@jhu.edu 443-287-9960 Johns Hopkins University Johns Hopkins researchers have discovered that a single protein molecule may hold the key to turning cardiac stem cells into blood vessels or muscle tissue, a finding that may lead to better ways to treat heart attack patients. Human heart tissue does not heal well after a heart attack, instead forming debilitating scars. For reasons not completely understood, however, stem cells can assist in this repair process by turning into the cells that make up healthy heart tissue, including heart muscle and blood vessels. Recently, doctors elsewhere have reported promising early results in the use of cardiac stem cells to curb the formation of unhealthy scar tissue after a heart attack. But the discovery of a "master molecule" that guides the destiny of these stem cells could result in even more effective treatments for heart patients, the Johns Hopkins researchers say. In a study published in the June 5 online edition of the journal Science Signaling, the team reported that tinkering with a protein molecule called p190RhoGAP shaped the development of cardiac stem cells, prodding them to become the building blocks for … Continue reading

Comments Off on 'Master molecule' may improve stem cell treatment of heart attacks

Tiny human liver grown inside mouse

Posted: Published on June 21st, 2012

It may be small, but is it perfectly formed? A tiny human liver, just 5 millimetres in size, has been grown inside a mouse. It remains to be seen whether the organ can replicate all liver functions and if it will be possible to scale up the tiny structure to useable dimensions. Hideki Taniguchi and Takanori Takebe at Yokohama City University generated induced pluripotent stem cells from human skin cells, then encouraged them to develop into liver precursor cells. They added two more types of cell mesenchymal cells, and endothelial cells from umbilical cord blood vessels. Without the aid of any underlying scaffold, the cells "guided themselves" and generated a microstructure almost identical to normal liver tissue, says Takebe. "We mixed and graded the cells onto the culture dish and they moved to form a cluster," he says. "It was a surprising outcome from what was, to be honest, an accident." The structure was then transplanted inside the skull of severe combined immunodeficiency mice, which would not mount an immune response to the tissue. Transplanting the structure here allowed the researchers to make use of the increased blood flow to the brain to encourage growth of the new tissue. Within … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Tiny human liver grown inside mouse

Tiny human liver grown inside mouse's head

Posted: Published on June 21st, 2012

It may be small, but is it perfectly formed? A tiny human liver, just 5 millimetres in size, has been grown inside a mouse. It remains to be seen whether the organ can replicate all liver functions and if it will be possible to scale up the tiny structure to useable dimensions. Hideki Taniguchi and Takanori Takebe at Yokohama City University generated induced pluripotent stem cells from human skin cells, then encouraged them to develop into liver precursor cells. They added two more types of cell mesenchymal cells, and endothelial cells from umbilical cord blood vessels. Without the aid of any underlying scaffold, the cells "guided themselves" and generated a microstructure almost identical to normal liver tissue, says Takebe. "We mixed and graded the cells onto the culture dish and they moved to form a cluster," he says. "It was a surprising outcome from what was, to be honest, an accident." The structure was then transplanted inside the skull of severe combined immunodeficiency mice, which would not mount an immune response to the tissue. Transplanting the structure here allowed the researchers to make use of the increased blood flow to the brain to encourage growth of the new tissue. Within … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Tiny human liver grown inside mouse's head

Cryo-Save Group N.V. awards researcher at grand opening of its new headquarters

Posted: Published on June 21st, 2012

The leading international family stem cell bank, Cryo-Save, celebrates the grand opening of its brand new headquarters office in Zutphen, the Netherlands, by honoring PhD. T.H.J. Nijhuis with the Young Investigator Award on June 22nd. Cryo-Save`s headquarters, located in Zutphen, the Netherlands, is celebrating the grand opening of its brand new, fully-renovated headquarters. On June 22nd, Arnoud van Tulder, CEO of Cryo-Save, and attorney-at-law C. Bieze, deputy in the province of Gelderland, will officially open the company`s new global headquarters office. To mark the occasion, the company will grant PhD. T.H.J. Nijhuis, winner of the Cryo-Save Young Investigator Award, a prize of 5,000 euros. Mr. Nijhuis has focused his most recent research on umbilical cord mesenchymal stem cells and pursues his work at the Erasmus Medical Center, part of the Erasmus University of Rotterdam, the Netherlands. Arnoud van Tulder, CEO of Cryo-Save, says "We are proud to name Mr. T.H.J. Nijhuis, as the winner of the Cryo-Save Young Investigator Award. Research is a cornerstone of the stem cell industry, and it`s advancements like that of Mr. T.H.J. Nijhuis that makes us so optimistic for the future." As part of Cryo-Save`s educational and community outreach efforts, the Cryo-Save Young Investigator Award … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Cryo-Save Group N.V. awards researcher at grand opening of its new headquarters

Scientists Can Now Grow Functioning Liver From Stem Cells [Medicine]

Posted: Published on June 21st, 2012

Scientists have promised a lot of regenerative medicine will come from stem cells, but so far progress has been fairly slow: they can stimualte regrowth of heart tissue, make incredibly expesnive artifical blood, orat bestconstruct a short piece of vein. Now, though, scientists are claiming they can grow functional liver. Nature reports that a team of scientists from Japan has presented its works at a conference, and it's incredible. In fact, George Daley, director of the stem-cell transplantation program at the Boston Children's Hospital in Massachusetts, told Nature that "it blew [his] mind." Wow. The researchers used stem cells created from human skin cells, then placed the cells on growth plates in a specially designed culture medium. Over the course of nine days, the cells started producing chemicals that a typical liver cell, otherwise known as a hepatocyte, would produce. They then added endothelial and mesenchymal cellswhich form parts of blood vessels and other structural tissues within the bodyto the mix, in the hope that they would be incorporated and begin to help the cells develop a structure akin to the liver. The result was amazing: two days later, the researchers found the cells assembled into a 5-millimeter-long, three-dimensional lump. … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Scientists Can Now Grow Functioning Liver From Stem Cells [Medicine]

Page 6,747«..1020..6,7466,7476,7486,749..6,7606,770..»